13F filing recap · Q2 2020

What did AKO Capital buy in Q2 2020?

Reported stock-position changes between this filing and the previous one.

Stock value

$5.73B

Positions

Estimated turnover

34.6%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

OTISOtis Worldwide Corporation$304.38Mreported value+5.35M shares CLBCore Laboratories Inc.$27.01Mreported value+1.33M shares

Increased positions

LINLinde Plc$877.41Mreported value+371.5K shares+9.8%EBAYEbay Inc.$443.61Mreported value+2.81M shares+49.7%VVisa Inc.$397.17Mreported value+262.5K shares+14.6%ELEstee Lauder Companies Inc$301.46Mreported value+435.9K shares

Reduced positions

RACEFerrari N.v.$323.04Mreported value-661.5K shares-25.9%PGProcter & Gamble Co$225.43Mreported value-193.8K shares-9.3%GRFSGrifols SA$223.87Mreported value-968.6K shares-7.3%ANSSAnsys Inc$202.79Mreported value-115.5K shares

Exited positions

UTXRtx Corporation$281.41Mprior reported value-2.98M shares-100.0%EWEdwards Lifesciences Corporation$142.14Mprior reported value-753.6K shares-100.0%AXPAmerican Express Co$130.67Mprior reported value-1.53M shares-100.0%